NOVO.B.DK

311

+0.19%↑

HLUNB.DK

40.12

+0.15%↑

AMBUB.DK

81.15

-0.79%↓

NOVO.B.DK

311

+0.19%↑

HLUNB.DK

40.12

+0.15%↑

AMBUB.DK

81.15

-0.79%↓

NOVO.B.DK

311

+0.19%↑

HLUNB.DK

40.12

+0.15%↑

AMBUB.DK

81.15

-0.79%↓

NOVO.B.DK

311

+0.19%↑

HLUNB.DK

40.12

+0.15%↑

AMBUB.DK

81.15

-0.79%↓

NOVO.B.DK

311

+0.19%↑

HLUNB.DK

40.12

+0.15%↑

AMBUB.DK

81.15

-0.79%↓

Search

Coloplast A-S (Class B)

Închisă

485.6 -0.45

Rezumat

Modificarea prețului

24h

Curent

Minim

479.6

Maxim

487.9

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

27.421

110.024

EPS

6.32

Randament dividend

4.84

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.84%

2.26%

Următoarele câștiguri

12 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-9.1B

110B

Deschiderea anterioară

486.05

Închiderea anterioară

485.6

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 feb. 2026, 23:44 UTC

Acțiuni populare

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 feb. 2026, 23:20 UTC

Câștiguri

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 feb. 2026, 22:57 UTC

Câștiguri

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 feb. 2026, 21:59 UTC

Câștiguri

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 feb. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 feb. 2026, 23:54 UTC

Market Talk

Global Equities Roundup: Market Talk

17 feb. 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 feb. 2026, 23:45 UTC

Market Talk

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 feb. 2026, 23:19 UTC

Câștiguri

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb. 2026, 23:15 UTC

Câștiguri

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb. 2026, 22:58 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 feb. 2026, 22:58 UTC

Achiziții, Fuziuni, Preluări

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 feb. 2026, 22:57 UTC

Achiziții, Fuziuni, Preluări

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 feb. 2026, 22:50 UTC

Achiziții, Fuziuni, Preluări

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 feb. 2026, 22:44 UTC

Câștiguri

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 feb. 2026, 22:42 UTC

Câștiguri

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 feb. 2026, 22:36 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 feb. 2026, 22:36 UTC

Câștiguri

Santos Final Dividend 10.3 U.S. Cents/Security

17 feb. 2026, 22:36 UTC

Câștiguri

Santos FY Underlying Profit US$898 Million, Down 25%

17 feb. 2026, 22:35 UTC

Câștiguri

Santos FY Revenue US$4.94 Billion, Down 8%

17 feb. 2026, 22:35 UTC

Câștiguri

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 feb. 2026, 22:35 UTC

Achiziții, Fuziuni, Preluări

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 feb. 2026, 22:34 UTC

Câștiguri

Santos FY Net Profit US$818 Billion, Down 33%

17 feb. 2026, 22:02 UTC

Achiziții, Fuziuni, Preluări

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 feb. 2026, 21:50 UTC

Achiziții, Fuziuni, Preluări

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 feb. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 feb. 2026, 21:49 UTC

Achiziții, Fuziuni, Preluări

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 feb. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 feb. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat